C
Last Price
52 Week Range
ZAR2.00 - ZAR6.90
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | ZAR619.39M |
EV | ZAR566.77M |
Shares Outstanding | 288.09M |
Beta | - |
Industry | Financial - Conglomerates |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
C
Cilo Cybin Holdings Limited
CCC
Sector
Financial Services
Industry
Financial - Conglomerates
CEO
Theron, Gabriel
Employees
Website
www.cilocybin.comIPO Date
2024-06-27
Headquarters
The Point Office Park, Unit C1, 7 Sterling Street, Samrand, Centurion, Gauteng, 0157 South Africa
The last closing price of Cilo Cybin Holdings (CCC) is ZAR2.15, reflecting a +0.00% change from the prior session. Last updated: December 31, 2025 at 2:50 AM Eastern Time
Review the recent CCC stock performance trends:Past 1 Month: Cilo Cybin Holdings (CCC) shares have -22.94%.Past 3 Months: The stock has -45.57%.Past 6 Months: CCC shares have -27.12%. Last updated: December 31, 2025 at 11:47 PM Eastern Time
Over the last year, Cilo Cybin Holdings (CCC) has established a 52-week price range between a high of ZAR6.90 and a low of ZAR2.00. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:47 PM Eastern Time
The current Cilo Cybin Holdings (CCC) market capitalization is approximately ZAR619.39M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Cilo Cybin Holdings's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:47 PM Eastern Time
Cilo Cybin Holdings (CCC) does not currently pay a dividend. Over the last twelve months (LTM), the company paid ZAR0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, Cilo Cybin Holdings (CCC) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 2:50 AM Eastern Time
Like other publicly traded stocks, Cilo Cybin Holdings (CCC) shares are bought and sold on stock exchanges such as JSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Cilo Cybin Holdings (CCC) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add CCC to your watchlist.
Cilo Cybin Holdings trades under the ticker symbol CCC on the JSE stock exchange. The ticker CCC is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
Cilo Cybin Holdings (CCC) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Cilo Cybin Holdings (CCC) stock peers based on overlapping products, services, and competitive dynamics:Enorama Pharma (ERMA)Labocanna (LCN)Stenocare (STENO)Blueberries Medical (BBM)Klaria Pharma Holding AB (publ.) (KLAR)IM Cannabis (IMCC) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Cilo Cybin Holdings.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.